Hans Carl Hasselbalch


Affiliation: University of Copenhagen
Country: Denmark


  1. Hasselbalch H. The platelet-cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?. Leuk Res. 2014;38:1230-6 pubmed publisher
  2. Enblom A, Lindskog E, Hasselbalch H, Hersby D, Bak M, Tetu J, et al. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms. Eur J Intern Med. 2015;26:344-7 pubmed publisher
    ..If MPN were diagnosed earlier, a large proportion of these events might be prevented. An MPN should always be suspected and ruled out in patients with unexplained elevated hematocrit, leukocyte and/or platelet counts. ..
  3. request reprint
    Ocias L, Holmström M, Riley C, Andersen C, Rønnov Jessen D, Starklint J, et al. [Status and perspectives on chronic myeloproliferative neoplasm treatment]. Ugeskr Laeger. 2015;177: pubmed
    ..This article reviews these new treatment options. ..
  4. request reprint
    Holmström M, Ocias L, Kallenbach K, Kjær L, Kristensen T, Pallisgaard N, et al. [New disease markers within the chronic myeloproliferative neoplasms]. Ugeskr Laeger. 2015;177: pubmed
    ..CALR mutations as a diagnostic and prognostic tool are promising and the mutations are potential targets for immune therapy. ..
  5. Hasselbalch H. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?. Blood. 2012;119:3219-25 pubmed publisher
  6. Hasselbalch H, Skov V, Larsen T, Thomassen M, Riley C, Jensen M, et al. High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis. Leuk Res. 2011;35:1330-4 pubmed publisher
  7. Hasselbalch H. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?. Leuk Res. 2013;37:214-20 pubmed publisher
  8. Hasselbalch H. A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?. Leuk Res. 2014;38:263-6 pubmed publisher
    ..Accordingly, this novel murine model may also have delivered the proof of concept of chronic inflammation as a trigger and driver of clonal evolution in MPNs. ..